Abstract
In recent years, the intensification of the use of immunosuppressive therapies has increased the incidence of invasive infections caused by opportunistic fungi. Considering that, the spread of azole resistance and amphotericin B (AmB) inefficiency against some clinical and environmental isolates has been described. Thus, to avoid a global problem when controlling fungal infections and critical failures in medicine, and food security, new approaches for drug target identification and for the development of new treatments that are more effective against pathogenic fungi are desired. Recent studies indicate that protein acetylation is present in hundreds of proteins of different cellular compartments and is involved in several biological processes, i.e., metabolism, translation, gene expression regulation, and oxidative stress response, from prokaryotes and eukaryotes, including fungi, demonstrating that lysine acetylation plays an important role in essential mechanisms. Lysine acetyltransferases (KATs) and lysine deacetylases (KDACs), the two enzyme families responsible for regulating protein acetylation levels, have been explored as drug targets for the treatment of several human diseases and infections. Aspergilli have on average 8 KAT genes and 11 KDAC genes in their genomes. This review aims to summarize the available knowledge about Aspergillus spp. azole resistance mechanisms and the role of lysine acetylation in the control of biological processes in fungi. We also want to discuss the lysine acetylation as a potential target for fungal infection treatment and drug target discovery.
Similar content being viewed by others
References
Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC (2012) Hidden killers: human fungal infections. Sci Transl Med 4:165rv13. https://doi.org/10.1126/scitranslmed.3004404
Fisher MC, Hawkins NJ, Sanglard D, Gurr SJ (2018) Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science 360:739–742. https://doi.org/10.1126/science.aap7999
Tudela JLR, Denning DW (2017) Recovery from serious fungal infections should be realisable for everyone. Lancet Infect Dis 17:1111–1113. https://doi.org/10.1016/S1473-3099(17)30319-5
Almeida F, Rodrigues ML, Coelho C (2019) The still underestimated problem of fungal diseases worldwide. Front Microbiol 10:214. https://doi.org/10.3389/fmicb.2019.00214
Casadevall A (2018) Fungal diseases in the 21st century: the near and far horizons. Pathog Immun 3:183–196. https://doi.org/10.20411/pai.v3i2.249
Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A (2017) The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 17:e383–e392. https://doi.org/10.1016/S1473-3099(17)30316-X
Sugui JA, Kwon-Chung KJ, Juvvadi PR, Latge J-P, Steinbach WJ (2015) Aspergillus fumigatus and related species. Cold Spring Harb Perspect Med 5:a019786–a019786. https://doi.org/10.1101/cshperspect.a019786
Kwon-Chung KJ, Sugui JA (2013) Aspergillus fumigatus—what makes the species a ubiquitous human fungal pathogen? PLoS Pathog 9:e1003743. https://doi.org/10.1371/journal.ppat.1003743
Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P, Denning DW (2007) Aspergillus flavus: human pathogen, allergen and mycotoxin producer. Microbiology 153:1677–1692. https://doi.org/10.1099/mic.0.2007/007641-0
Arrowsmith CH, Bountra C, Fish PV, Lee K, Schapira M (2012) Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov 11:384–400. https://doi.org/10.1038/nrd3674
Downey M, Baetz K (2016) Building a KATalogue of acetyllysine targeting and function. Brief Funct Genomics 15:109–118. https://doi.org/10.1093/bfgp/elv045
Choudhary C, Weinert BT, Nishida Y, Verdin E, Mann M (2014) The growing landscape of lysine acetylation links metabolism and cell signalling. Nat Rev Mol Cell Biol 15:536–550. https://doi.org/10.1038/nrm3841
Kuchler K, Jenull S, Shivarathri R, Chauhan N (2016) Fungal KATs/KDACs: a new highway to better antifungal drugs? PLoS Pathog 12:e1005938. https://doi.org/10.1371/journal.ppat.1005938
Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux J-P, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA (2018) Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect 24:e1–e38. https://doi.org/10.1016/j.cmi.2018.01.002
Miceli MH, Kauffman CA (2015) Isavuconazole: a new broad-Spectrum triazole antifungal agent. Clin Infect Dis 61:1558–1565. https://doi.org/10.1093/cid/civ571
Lass-Flörl C (2011) Triazole antifungal agents in invasive fungal infections. Drugs 71:2405–2419. https://doi.org/10.2165/11596540-000000000-00000
Verweij PE, Chowdhary A, Melchers WJG, Meis JF (2016) Azole resistance in Aspergillus fumigatus : can we retain the clinical use of mold-active antifungal azoles? Clin Infect Dis 62:362–368. https://doi.org/10.1093/cid/civ885
Snelders E, van der Lee HAL, Kuijpers J, Rijs AJMM, Varga J, Samson RA, Mellado E, Donders ART, Melchers WJG, Verweij PE (2008) Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 5:e219. https://doi.org/10.1371/journal.pmed.0050219
Arendrup MC, Mavridou E, Mortensen KL, Snelders E, Frimodt-Møller N, Khan H, Melchers WJG, Verweij PE (2010) Development of azole resistance in aspergillus fumigatus during azole therapy associated with change in virulence. PLoS One. https://doi.org/10.1371/journal.pone.0010080
Lamoth F (2016) Aspergillus fumigatus-related species in clinical practice. Front Microbiol 7:683. https://doi.org/10.3389/fmicb.2016.00683
Meis JF, Chowdhary A, Rhodes JL, Fisher MC, Verweij PE (2016) Clinical implications of globally emerging azole resistance in Aspergillus fumigatus. Philos Trans R Soc B Biol Sci 371:20150460. https://doi.org/10.1098/rstb.2015.0460
Resendiz Sharpe A, Lagrou K, Meis JF, Chowdhary A, Lockhart SR, Verweij PE (2018) Triazole resistance surveillance in Aspergillus fumigatus. Med Mycol 56:S83–S92. https://doi.org/10.1093/mmy/myx144
Mellado E, Diaz-Guerra TM, Cuenca-Estrella M, Rodriguez-Tudela JL (2001) Identification of two different 14-α sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species. J Clin Microbiol 39:2431–2438. https://doi.org/10.1128/JCM.39.7.2431-2438.2001
Hagiwara D, Watanabe A, Kamei K, Goldman GH (2016) Epidemiological and genomic landscape of azole resistance mechanisms in Aspergillus fungi. Front Microbiol 7:1382. https://doi.org/10.3389/fmicb.2016.01382
Bodey GP (1992) Azole antifungal agents. Clin Infect Dis 14:S161–S169. https://doi.org/10.1093/clinids/14.Supplement_1.S161
Snelders E, Karawajczyk A, Schaftenaar G, Verweij PE, Melchers WJG (2010) Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling. Antimicrob Agents Chemother 54:2425–2430. https://doi.org/10.1128/AAC.01599-09
Snelders E, Camps SMT, Karawajczyk A, Schaftenaar G, Kema GHJ, van der Lee HA, Klaassen CH, Melchers WJG, Verweij PE (2012) Triazole fungicides can induce cross-resistance to medical triazoles in Aspergillus fumigatus. PLoS One 7:e31801. https://doi.org/10.1371/journal.pone.0031801
van der Linden JWM, Camps SMT, Kampinga GA, Arends JPA, Debets-Ossenkopp YJ, Haas PJA, Rijnders BJA, Kuijper EJ, van Tiel FH, Varga J, Karawajczyk A, Zoll J, Melchers WJG, Verweij PE (2013) Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis 57:513–520. https://doi.org/10.1093/cid/cit320
Howard SJ, Pasqualotto AC, Anderson MJ, Leatherbarrow H, Albarrag AM, Harrison E, Gregson L, Bowyer P, Denning DW (2013) Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis. Mycoses 56:434–441. https://doi.org/10.1111/myc.12047
Rodriguez-Tudela JL, Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Monzon A, Cuenca-Estrella M (2008) Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Antimicrob Agents Chemother 52:2468–2472. https://doi.org/10.1128/AAC.00156-08
Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC, Laverdiere M, Arendrup MC, Perlin DS, Denning DW (2009) Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure1. Emerg Infect Dis 15:1068–1076. https://doi.org/10.3201/eid1507.090043
Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL (2004) Substitutions at methionine 220 in the 14α-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother 48:2747–2750. https://doi.org/10.1128/AAC.48.7.2747-2750.2004
Liu M, Zheng N, Li D, Zheng H, Zhang L, Ge H, Liu W (2016) cyp51A -based mechanism of azole resistance in Aspergillus fumigatus : illustration by a new 3D structural model of Aspergillus fumigatus CYP51A protein. Med Mycol 54:400–408. https://doi.org/10.1093/mmy/myv102
Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Melchers WJG, Verweij PE, Cuenca-Estrella M, Rodriguez-Tudela JL (2007) A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother 51:1897–1904. https://doi.org/10.1128/AAC.01092-06
Vermeulen E, Maertens J, Schoemans H, Lagrou K (2012) Azole-resistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation emerging in Belgium, July 2012. Eurosurveillance. https://doi.org/10.2807/ese.17.48.20326-en
Alvarez-Moreno C, Lavergne R-A, Hagen F, Morio F, Meis JF, Le Pape P (2017) Azole-resistant Aspergillus fumigatus harboring TR34/L98H, TR46/Y121F/T289A and TR53 mutations related to flower fields in Colombia. Sci Rep 7:45631. https://doi.org/10.1038/srep45631
Hare RK, Gertsen JB, Astvad KMT, Degn KB, Løkke A, Stegger M, Andersen PS, Kristensen L, Arendrup MC (2019) In vivo selection of a unique tandem repeat mediated azole resistance mechanism (TR 120 ) in Aspergillus fumigatus cyp51A, Denmark. Emerg Infect Dis 25:577–580. https://doi.org/10.3201/eid2503.180297
Verweij PE, Kema GHJ, Zwaan B, Melchers WJ (2013) Triazole fungicides and the selection of resistance to medical triazoles in the opportunistic mould Aspergillus fumigatus. Pest Manag Sci 69:165–170. https://doi.org/10.1002/ps.3390
Chowdhary A, Kathuria S, Xu J, Meis JF (2013) Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog 9:e1003633. https://doi.org/10.1371/journal.ppat.1003633
Rajendran R, Mowat E, McCulloch E, Lappin DF, Jones B, Lang S, Majithiya JB, Warn P, Williams C, Ramage G (2011) Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity. Antimicrob Agents Chemother 55:2092–2097. https://doi.org/10.1128/AAC.01189-10
Nascimento AM, Goldman GH, Park S, Marras SAE, Delmas G, Oza U, Lolans K, Dudley MN, Mann PA, Perlin DS (2003) Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob Agents Chemother 47:1719–1726. https://doi.org/10.1128/AAC.47.5.1719-1726.2003
da Silva Ferreira ME, Capellaro JL, dos Reis Marques E, Malavazi I, Perlin D, Park S, Anderson JB, Colombo AL, Arthington-Skaggs BA, Goldman MHS, Goldman GH (2004) In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance. Antimicrob Agents Chemother 48:4405–4413. https://doi.org/10.1128/AAC.48.11.4405-4413.2004
Hagiwara D, Miura D, Shimizu K, Paul S, Ohba A, Gonoi T, Watanabe A, Kamei K, Shintani T, Moye-Rowley WS, Kawamoto S, Gomi K (2017) A novel Zn2-Cys6 transcription factor AtrR plays a key role in an azole resistance mechanism of Aspergillus fumigatus by co-regulating cyp51A and cdr1B expressions. PLoS Pathog 13:e1006096. https://doi.org/10.1371/journal.ppat.1006096
Paul S, Diekema D, Moye-Rowley WS (2013) Contributions of Aspergillus fumigatus ATP-binding cassette transporter proteins to drug resistance and virulence. Eukaryot Cell 12:1619–1628. https://doi.org/10.1128/EC.00171-13
Camps SMT, Dutilh BE, Arendrup MC, Rijs AJMM, Snelders E, Huynen MA, Verweij PE, Melchers WJG (2012) Discovery of a hapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing. PLoS One 7:e50034. https://doi.org/10.1371/journal.pone.0050034
Gsaller F, Hortschansky P, Furukawa T, Carr PD, Rash B, Capilla J, Müller C, Bracher F, Bowyer P, Haas H, Brakhage AA, Bromley MJ (2016) Sterol biosynthesis and azole tolerance is governed by the opposing actions of SrbA and the CCAAT binding complex. PLoS Pathog 12:e1005775. https://doi.org/10.1371/journal.ppat.1005775
Willger SD, Puttikamonkul S, Kim K-H, Burritt JB, Grahl N, Metzler LJ, Barbuch R, Bard M, Lawrence CB, Cramer RA (2008) A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus. PLoS Pathog 4:e1000200. https://doi.org/10.1371/journal.ppat.1000200
Hagiwara D, Watanabe A, Kamei K (2016) Sensitisation of an azole-resistant Aspergillus fumigatus strain containing the Cyp51A-related mutation by deleting the SrbA gene. Sci Rep 6:38833. https://doi.org/10.1038/srep38833
Wei X, Chen P, Gao R, Li Y, Zhang A, Liu F, Lu L (2017) Screening and characterization of a non-cyp51A mutation in an Aspergillus fumigatus cox10 strain conferring azole resistance. Antimicrob Agents Chemother 61. https://doi.org/10.1128/AAC.02101-16
Gonçalves SS, Souza ACR, Chowdhary A, Meis JF, Colombo AL (2016) Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus. Mycoses 59:198–219. https://doi.org/10.1111/myc.12469
Perlin DS (2015) Mechanisms of echinocandin antifungal drug resistance. Ann N Y Acad Sci 1354:1–11. https://doi.org/10.1111/nyas.12831
Jiménez-Ortigosa C, Moore C, Denning DW, Perlin DS (2017) Emergence of echinocandin resistance due to a point mutation in the fks1 gene of Aspergillus fumigatus in a patient with chronic pulmonary aspergillosis. Antimicrob Agents Chemother 61:e01277–e01217. https://doi.org/10.1128/AAC.01277-17
Narita T, Weinert BT, Choudhary C (2019) Functions and mechanisms of non-histone protein acetylation. Nat Rev Mol Cell Biol 20:156–174. https://doi.org/10.1038/s41580-018-0081-3
Allfrey VG, Mirsky AE (1964) Structural modifications of histones and their possible role in the regulation of RNA synthesis. Science 144:559–559. https://doi.org/10.1126/science.144.3618.559
Castaño-Cerezo S, Bernal V, Röhrig T, Termeer S, Cánovas M (2015) Regulation of acetate metabolism in Escherichia coli BL21 by protein Nε-lysine acetylation. Appl Microbiol Biotechnol 99:3533–3545. https://doi.org/10.1007/s00253-014-6280-8
Moretti NS, Cestari I, Anupama A, Stuart K, Schenkman S (2018) Comparative proteomic analysis of lysine acetylation in trypanosomes. J Proteome Res 17:374–385. https://doi.org/10.1021/acs.jproteome.7b00603
Hong Y, Cao X, Han Q, Yuan C, Zhang M, Han Y, Zhu C, Lin T, Lu K, Li H, Fu Z, Lin J (2016) Proteome-wide analysis of lysine acetylation in adult Schistosoma japonicum worm. J Proteome 148:202–212. https://doi.org/10.1016/j.jprot.2016.08.008
Hartl M, Füßl M, Boersema PJ, Jost J, Kramer K, Bakirbas A, Sindlinger J, Plöchinger M, Leister D, Uhrig G, Moorhead GB, Cox J, Salvucci ME, Schwarzer D, Mann M, Finkemeier I (2017) Lysine acetylome profiling uncovers novel histone deacetylase substrate proteins in Arabidopsis. Mol Syst Biol 13:949. https://doi.org/10.15252/msb.20177819
Weinert BT, Wagner SA, Horn H, Henriksen P, Liu WR, Olsen JV, Jensen LJ, Choudhary C (2011) Proteome-wide mapping of the Drosophila acetylome demonstrates a high degree of conservation of lysine acetylation. Sci Signal 4:ra48. https://doi.org/10.1126/scisignal.2001902
Lundby A, Lage K, Weinert BT, Bekker-Jensen DB, Secher A, Skovgaard T, Kelstrup CD, Dmytriyev A, Choudhary C, Lundby C, Olsen JV (2012) Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns. Cell Rep 2:419–431. https://doi.org/10.1016/j.celrep.2012.07.006
Weinert BT, Iesmantavicius V, Moustafa T, Schölz C, Wagner SA, Magnes C, Zechner R, Choudhary C (2014) Acetylation dynamics and stoichiometry in Saccharomyces cerevisiae. Mol Syst Biol 10:716. https://doi.org/10.1002/msb.134766
Li Y, Li H, Sui M, Li M, Wang J, Meng Y, Sun T, Liang Q, Suo C, Gao X, Li C, Li Z, Du W, Zhang B, Sai S, Zhang Z, Ye J, Wang H, Yue S, Li J, Zhong M, Chen C, Qi S, Lu L, Li D, Ding C (2019) Fungal acetylome comparative analysis identifies an essential role of acetylation in human fungal pathogen virulence. Commun Biol 2:154. https://doi.org/10.1038/s42003-019-0419-1
Zhou T, Chung Y, Chen J, Chen Y (2016) Site-specific identification of lysine acetylation stoichiometries in mammalian cells. J Proteome Res 15:1103–1113. https://doi.org/10.1021/acs.jproteome.5b01097
Henriksen P, Wagner SA, Weinert BT, Sharma S, Bačinskaja G, Rehman M, Juffer AH, Walther TC, Lisby M, Choudhary C (2012) Proteome-wide analysis of lysine acetylation suggests its broad regulatory scope in Saccharomyces cerevisiae. Mol Cell Proteomics 11:1510–1522. https://doi.org/10.1074/mcp.M112.017251
Li D, Lv B, Tan L, Yang Q, Liang W (2016) Acetylome analysis reveals the involvement of lysine acetylation in diverse biological processes in Phytophthora sojae. Sci Rep 6:29897. https://doi.org/10.1038/srep29897
Lv B, Yang Q, Li D, Liang W, Song L (2016) Proteome-wide analysis of lysine acetylation in the plant pathogen Botrytis cinerea. Sci Rep 6:29313. https://doi.org/10.1038/srep29313
Xie L, Fang W, Deng W, Yu Z, Li J, Chen M, Liao W, Xie J, Pan W (2016) Global profiling of lysine acetylation in human histoplasmosis pathogen Histoplasma capsulatum. Int J Biochem Cell Biol. https://doi.org/10.1016/j.biocel.2016.01.008
Zhou S, Yang Q, Yin C, Liu L, Liang W (2016) Systematic analysis of the lysine acetylome in Fusarium graminearum. BMC Genomics 17:1019. https://doi.org/10.1186/s12864-016-3361-3
Zheng H, He Y, Zhou X, Qian G, Lv G, Shen Y, Liu J, Li D, Li X, Liu W (2016) Systematic analysis of the lysine succinylome in Candida albicans. J Proteome Res 15:3793–3801. https://doi.org/10.1021/acs.jproteome.6b00578
Lv Y (2017) Proteome-wide profiling of protein lysine acetylation in Aspergillus flavus. PLoS One 12:7–9. https://doi.org/10.1371/journal.pone.0178603
Wang ZK, Cai Q, Liu J, Ying SH, Feng MG (2017) Global insight into lysine acetylation events and their links to biological aspects in Beauveria bassiana, a fungal insect pathogen. Sci Rep 7:44360. https://doi.org/10.1038/srep44360
Liang M, Zhang S, Dong L, Kou Y, Lin C, Dai W, Zhang L-H, Deng YZ (2018) Label-free quantitative proteomics of lysine acetylome identifies substrates of Gcn5 in Magnaporthe oryzae autophagy and epigenetic regulation. mSystems 3:e00270–e00218. https://doi.org/10.1128/msystems.00270-18
Xu X, Liu T, Yang J, Chen L, Liu B, Wang L, Jin Q (2018) The first whole-cell proteome- and lysine-acetylome-based comparison between Trichophyton rubrum conidial and mycelial stages. J Proteome Res 17:1436–1451. https://doi.org/10.1021/acs.jproteome.7b00793
Wang G, Guo L, Liang W, Chi Z, Liu L (2017) Systematic analysis of the lysine acetylome reveals diverse functions of lysine acetylation in the oleaginous yeast Yarrowia lipolytica. AMB Express 7:94. https://doi.org/10.1186/s13568-017-0393-2
Wurtele H, Tsao S, Lépine G, Mullick A, Tremblay J, Drogaris P, Lee E-H, Thibault P, Verreault A, Raymond M (2010) Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy. Nat Med 16:774–780. https://doi.org/10.1038/nm.2175
Carrozza MJ, Utley RT, Workman JL, Côté J (2003) The diverse functions of histone acetyltransferase complexes. Trends Genet 19:321–329. https://doi.org/10.1016/S0168-9525(03)00115-X
Tang Y, Holbert MA, Wurtele H, Meeth K, Rocha W, Gharib M, Jiang E, Thibault P, Verreault A, Cole PA, Marmorstein R (2008) Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP. Nat Struct Mol Biol 15:738–745. https://doi.org/10.1038/nsmb.1448
Roth SY, Denu JM, Allis CD (2001) Histone acetyltransferases. Annu Rev Biochem 70:81–120. https://doi.org/10.1146/annurev.biochem.70.1.81
Mizzen CA, Yang X-J, Kokubo T, Brownell JE, Bannister AJ, Owen-Hughes T, Workman J, Wang L, Berger SL, Kouzarides T, Nakatani Y, Allis CD (1996) The TAFII250 subunit of TFIID has histone acetyltransferase activity. Cell 87:1261–1270. https://doi.org/10.1016/S0092-8674(00)81821-8
Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai M-J, O’Malley BW (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194–198. https://doi.org/10.1038/38304
Doi M, Hirayama J, Sassone-Corsi P (2006) Circadian regulator CLOCK is a histone acetyltransferase. Cell 125:497–508. https://doi.org/10.1016/j.cell.2006.03.033
Wang L, Tang Y, Cole PA, Marmorstein R (2008) Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function. Curr Opin Struct Biol 18:741–747. https://doi.org/10.1016/j.sbi.2008.09.004
Brosch G, Loidl P, Graessle S (2008) Histone modifications and chromatin dynamics: a focus on filamentous fungi. FEMS Microbiol Rev 32:409–439. https://doi.org/10.1111/j.1574-6976.2007.00100.x
Ren J, Sang Y, Lu J, Yao Y-F (2017) Protein acetylation and its role in bacterial virulence. Trends Microbiol 25:768–779. https://doi.org/10.1016/j.tim.2017.04.001
Yuan H, Marmorstein R (2012) Structural basis for Sirtuin activity and inhibition. J Biol Chem 287:42428–42435. https://doi.org/10.1074/jbc.R112.372300
Troejer P, Brandtner EM, Brosch G, Loidl P, Galehr J, Linzmaier R, Haas H, Mair K, Tribus M, Graessle S (2003) Histone deacetylases in fungi: novel members, new facts. Nucleic Acids Res 31:3971–3981. https://doi.org/10.1093/nar/gkg473
Itoh E, Shigemoto R, Oinuma K-I, Shimizu M, Masuo S, Takaya N (2017) Sirtuin A regulates secondary metabolite production by Aspergillus nidulans. J Gen Appl Microbiol 63:228–235. https://doi.org/10.2323/jgam.2016.11.002
Van Dyke MW (2014) Lysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulation. ChemMedChem 9:511–522. https://doi.org/10.1002/cmdc.201300444
Seto E, Yoshida M (2014) Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol 6:a018713–a018713. https://doi.org/10.1101/cshperspect.a018713
Georgakopoulos P, Lockington RA, Kelly JM (2013) The Spt-Ada-Gcn5 acetyltransferase (SAGA) complex in Aspergillus nidulans. PLoS One. https://doi.org/10.1371/journal.pone.0065221
Reyes-Dominguez Y, Narendja F, Berger H, Gallmetzer A, Fernandez-Martin R, Garcia I, Scazzocchio C, Strauss J (2008) Nucleosome positioning and histone H3 acetylation are independent processes in the Aspergillus nidulans prnD-prnB bidirectional promoter. Eukaryot Cell 7:656–663. https://doi.org/10.1128/EC.00184-07
Cánovas D, Marcos AT, Gacek A, Ramos MS, Gutiérrez G, Reyes-Domínguez Y, Strauss J (2014) The histone acetyltransferase GcnE (GCN5) plays a central role in the regulation of Aspergillus asexual development. Genetics 197:1175–1189. https://doi.org/10.1534/genetics.114.165688
Nutzmann H-W, Reyes-Dominguez Y, Scherlach K, Schroeckh V, Horn F, Gacek A, Schumann J, Hertweck C, Strauss J, Brakhage AA (2011) Bacteria-induced natural product formation in the fungus Aspergillus nidulans requires Saga/Ada-mediated histone acetylation. Proc Natl Acad Sci 108:14282–14287. https://doi.org/10.1073/pnas.1103523108
Lan H, Sun R, Fan K, Yang K, Zhang F, Nie XY, Wang X, Zhuang Z, Wang S (2016) The Aspergillus flavus histone acetyltransferase aflgcne regulates morphogenesis, aflatoxin biosynthesis, and pathogenicity. Front Microbiol 7:1324. https://doi.org/10.3389/fmicb.2016.01324
Smith ER, Eisen A, Gu W, Sattah M, Pannuti A, Zhou J, Cook RG, Lucchesi JC, Allis CD (1998) ESA1 is a histone acetyltransferase that is essential for growth in yeast. Proc Natl Acad Sci 95:3561–3565. https://doi.org/10.1073/pnas.95.7.3561
Soukup AA, Chiang Y-M, Bok JW, Reyes-Dominguez Y, Oakley BR, Wang CCC, Strauss J, Keller NP (2012) Overexpression of the Aspergillus nidulans histone 4 acetyltransferase EsaA increases activation of secondary metabolite production. Mol Microbiol 86:314–330. https://doi.org/10.1111/j.1365-2958.2012.08195.x
Roze LV, Koptina AV, Laivenieks M, Beaudry RM, Jones DA, Kanarsky AV, Linz JE (2011) Willow volatiles influence growth, development, and secondary metabolism in Aspergillus parasiticus. Appl Microbiol Biotechnol 92:359–370. https://doi.org/10.1007/s00253-011-3339-7
Driscoll R, Hudson A, Jackson SP (2007) Yeast Rtt109 promotes genome stability by acetylating histone H3 on lysine 56. Science 315:649–652. https://doi.org/10.1126/science.1135862
Lopes da Rosa J, Bajaj V, Spoonamore J, Kaufman PD (2013) A small molecule inhibitor of fungal histone acetyltransferase Rtt109. Bioorg Med Chem Lett 23:2853–2859. https://doi.org/10.1016/j.bmcl.2013.03.112
Bauer I, Varadarajan D, Pidroni A, Gross S, Vergeiner S, Faber B, Hermann M, Tribus M, Brosch G, Graessle S (2016) A class 1 histone deacetylase with potential as an antifungal target. MBio 7. https://doi.org/10.1128/mBio.00831-16
Graessle S, Dangl M, Haas H, Mair K, Trojer P, Brandtner E-M, Walton JD, Loidl P, Brosch G (2000) Characterization of two putative histone deacetylase genes from Aspergillus nidulans. Biochim Biophys Acta - Gene Struct Expr 1492:120–126. https://doi.org/10.1016/S0167-4781(00)00093-2
Tribus M, Bauer I, Galehr J, Rieser G, Trojer P, Brosch G, Loidl P, Haas H, Graessle S (2010) A novel motif in fungal class 1 histone deacetylases is essential for growth and development of Aspergillus. Mol Biol Cell 21:345–353. https://doi.org/10.1091/mbc.e09-08-0750
Kawauchi M, Iwashita K (2014) Functional analysis of histone deacetylase and its role in stress response, drug resistance and solid-state cultivation in Aspergillus oryzae. J Biosci Bioeng 118:172–176. https://doi.org/10.1016/j.jbiosc.2014.02.004
Kawauchi M, Nishiura M, Iwashita K (2013) Fungus-specific Sirtuin HstD coordinates secondary metabolism and development through control of LaeA. Eukaryot Cell 12:1087–1096. https://doi.org/10.1128/EC.00003-13
Pidroni A, Faber B, Brosch G, Bauer I, Graessle S (2018) A class 1 histone deacetylase as major regulator of secondary metabolite production in Aspergillus nidulans. Front Microbiol 9:2212. https://doi.org/10.3389/fmicb.2018.02212
Tribus M, Galehr J, Trojer P, Brosch G, Loidl P, Marx F, Haas H, Graessle S (2005) HdaA, a major class 2 histone deacetylase of Aspergillus nidulans, affects growth under conditions of oxidative stress. Eukaryot Cell 4:1736–1745. https://doi.org/10.1128/EC.4.10.1736-1745.2005
Lee I, Oh J-H, Keats Shwab E, Dagenais TRT, Andes D, Keller NP (2009) HdaA, a class 2 histone deacetylase of Aspergillus fumigatus, affects germination and secondary metabolite production. Fungal Genet Biol 46:782–790. https://doi.org/10.1016/j.fgb.2009.06.007
Lara E, Mai A, Calvanese V, Altucci L, Lopez-Nieva P, Martinez-Chantar ML, Varela-Rey M, Rotili D, Nebbioso A, Ropero S, Montoya G, Oyarzabal J, Velasco S, Serrano M, Witt M, Villar-Garea A, Inhof A, Mato JM, Esteller M, Fraga MF (2009) Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect. Oncogene 28:781–791. https://doi.org/10.1038/onc.2008.436
Itoh E, Odakura R, Oinuma K-I, Shimizu M, Masuo S, Takaya N (2017) Sirtuin E is a fungal global transcriptional regulator that determines the transition from the primary growth to the stationary phase. J Biol Chem 292:11043–11054. https://doi.org/10.1074/jbc.M116.753772
Shwab EK, Bok JW, Tribus M, Galehr J, Graessle S, Keller NP (2007) Histone deacetylase activity regulates chemical diversity in Aspergillus. Eukaryot Cell. https://doi.org/10.1128/EC.00186-07
Uhrig RG, Schläpfer P, Mehta D, Hirsch-Hoffmann M, Gruissem W (2017) Genome-scale analysis of regulatory protein acetylation enzymes from photosynthetic eukaryotes. BMC Genomics 18:514. https://doi.org/10.1186/s12864-017-3894-0
Nie X, Li B, Wang S (2018) Epigenetic and posttranslational modifications in regulating the biology of Aspergillus species. Adv Appl Microbiol. https://doi.org/10.1016/bs.aambs.2018.05.004
Menzies KJ, Zhang H, Katsyuba E, Auwerx J (2016) Protein acetylation in metabolism—metabolites and cofactors. Nat Rev Endocrinol 12:43–60. https://doi.org/10.1038/nrendo.2015.181
Lamoth F, Juvvadi PR, Steinbach WJ (2015) Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis. Front Microbiol 6:96. https://doi.org/10.3389/fmicb.2015.00096
Tsuju N, Kobayashi M, Nagashima K, Wakisaka Y, Koizumi K (1976) A new antifungal antibiotic, trichostatin. J Antibiot (Tokyo) 29:1–6. https://doi.org/10.7164/antibiotics.29.1
Lamoth F, Juvvadi PR, Soderblom EJ, Moseley MA, Asfaw YG, Steinbach WJ (2014) Identification of a key lysine residue in heat shock protein 90 required for azole and echinocandin resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 58:1889–1896. https://doi.org/10.1128/AAC.02286-13
Robbins N, Leach MD, Cowen LE (2012) Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance. Cell Rep 2:878–888. https://doi.org/10.1016/j.celrep.2012.08.035
Nguyen LN, Lopes LCL, Cordero RJB, Nosanchuk JD (2011) Sodium butyrate inhibits pathogenic yeast growth and enhances the functions of macrophages. J Antimicrob Chemother 66:2573–2580. https://doi.org/10.1093/jac/dkr358
Brandão FAS, Derengowski LS, Albuquerque P, Nicola AM, Silva-Pereira I, Poças-Fonseca MJ (2015) Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypes. Virulence 6:618–630. https://doi.org/10.1080/21505594.2015.1038014
Pfaller MA, Messer SA, Georgopapadakou N, Martell LA, Besterman JM, Diekema DJ (2009) Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens. J Clin Microbiol 47:3797–3804. https://doi.org/10.1128/JCM.00618-09
Avalos JL, Bever KM, Wolberger C (2005) Mechanism of sirtuin inhibition by nicotinamide: altering the NAD+ cosubstrate specificity of a Sir2 enzyme. Mol Cell 17:855–868. https://doi.org/10.1016/j.molcel.2005.02.022
Ciebiada-Adamiec A, Małafiej E, Ciebiada I (2010) Inhibitory effect of nicotinamide on enzymatic activity of selected fungal strains causing skin infection. Mycoses 53:204–207. https://doi.org/10.1111/j.1439-0507.2009.01696.x
Shigemoto R, Matsumoto T, Masuo S, Takaya N (2018) 5-Methylmellein is a novel inhibitor of fungal sirtuin and modulates fungal secondary metabolite production. J Gen Appl Microbiol 64:240–247. https://doi.org/10.2323/jgam.2018.01.001
Balasubramanyam K, Altaf M, Varier RA, Swaminathan V, Ravindran A, Sadhale PP, Kundu TK (2004) Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem 279:33716–33726. https://doi.org/10.1074/jbc.M402839200
O’Meara TR, Hay C, Price MS, Giles S, Alspaugh JA (2010) Cryptococcus neoformans histone acetyltransferase Gcn5 regulates fungal adaptation to the host. Eukaryot Cell 9:1193–1202. https://doi.org/10.1128/EC.00098-10
Muzaffar S, Bose C, Banerji A, Nair BG, Chattoo BB (2016) Anacardic acid induces apoptosis-like cell death in the rice blast fungus Magnaporthe oryzae. Appl Microbiol Biotechnol 100:323–335. https://doi.org/10.1007/s00253-015-6915-4
Sanglard D (2016) Emerging threats in antifungal-resistant fungal pathogens. Front Med 3:11. https://doi.org/10.3389/fmed.2016.00011
Block TM, Rawat S, Brosgart CL, Francisco S (2017) HHS Public Access 6:69–81. https://doi.org/10.1016/j.antiviral.2015.06.014.Chronic
Chandrasekar PH (2005) Antifungal resistance in Aspergillus. Med Mycol 43:295–298. https://doi.org/10.1080/13693780400029130
Mukherjee P, Wang M (2009) Antifungal drug resistance. In: Antifungal Therapy, 1st edn. CRC press: Informa Healthcare, New York, pp 63–86
West AC, Johnstone RW (2014) New and emerging HDAC inhibitors for cancer treatment. J Clin Invest 124:30–39. https://doi.org/10.1172/JCI69738
Mann BS, Johnson JR, Cohen MH, Justice R, Pazdur R (2007) FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist 12:1247–1252. https://doi.org/10.1634/theoncologist.12-10-1247
Grant C, Rahman F, Piekarz R, Peer C, Frye R, Robey RW, Gardner ER, Figg WD, Bates SE (2010) Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors. Expert Rev Anticancer Ther 10:997–1008. https://doi.org/10.1586/era.10.88
Sawas A, Radeski D, O’Connor OA (2015) Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective review. Ther Adv Hematol 6:202–208. https://doi.org/10.1177/2040620715592567
Moore D (2016) Panobinostat (farydak): a novel option for the treatment of relapsed or relapsed and refractory multiple myeloma. P & T 41:296–300
Yoon S, Eom GH (2016) HDAC and HDAC inhibitor: from cancer to cardiovascular diseases. Chonnam Med J 52:1–11. https://doi.org/10.4068/cmj.2016.52.1.1
Li Y, Seto E (2016) HDACs and HDAC inhibitors in cancer development and therapy. Cold Spring Harb Perspect Med 6:a026831. https://doi.org/10.1101/cshperspect.a026831
Ning Z-Q, Li Z-B, Newman MJ, Shan S, Wang X-H, Pan D-S, Zhang J, Dong M, Du X, Lu X-P (2012) Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity. Cancer Chemother Pharmacol 69:901–909. https://doi.org/10.1007/s00280-011-1766-x
Funding
The authors acknowledge the São Paulo Research Foundation (FAPESP) for the grants and fellowships provided (2017/22669-0 to AD; 2018/09948-0 to NSM). The authors also acknowledge the National Council for Scientific and Technological Development (CNPq) for the financial support (404654/2018-5 and 304816/2017-5 to AD; 424729/2018-0 to NSM; 123313/2018-0 to ABL). The authors acknowledge the Espaço da Escrita – Pró-Reitoria de Pesquisa – UNICAMP – for the language services provided.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Responsible Editor: Luis Henrique Souza Guimaraes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(XLSX 16 kb)
Rights and permissions
About this article
Cite this article
Wassano, N.S., Leite, A.B., Reichert-Lima, F. et al. Lysine acetylation as drug target in fungi: an underexplored potential in Aspergillus spp.. Braz J Microbiol 51, 673–683 (2020). https://doi.org/10.1007/s42770-020-00253-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42770-020-00253-w